Henry A. Glick

Best Publications

• Economic Evaluation in Clinical Trials

  Henry Robert Glick;Jalpa A. Doshi;Seema S. Sonnad;Daniel Polsky

  1379
  Citations

• A randomized, controlled trial of financial incentives for smoking cessation.

  Kevin G Volpp;Andrea B Troxel;Mark V Pauly;Henry A Glick

  1043
  Citations

• Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

  Scott D. Ramsey;Scott D. Ramsey;Richard J. Willke;Henry Glick;Shelby D. Reed

  854
  Citations

• Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report

  Scott Ramsey;Richard Willke;Andrew Briggs;Ruth Brown

  844
  Citations

• Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report

  Michael Drummond;Marco Barbieri;John Cook;Henry A. Glick

  602
  Citations

• Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.

  Adam Gilden Tsai;David F. Williamson;Henry A. Glick

  590
  Citations

• Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs

  Mark S. Bauer;M.S.N. Linda McBride;William O. Williford;Henry Glick

  374
  Citations

• Confidence intervals for cost-effectiveness ratios: A comparison of four methods

  Daniel Polsky;Henry A. Glick;Richard Willke;Kevin Schulman

  359
  Citations

• Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

  A L Hillman;J M Eisenberg;M V Pauly;B S Bloom

  320
  Citations

• A Randomized, Controlled Trial of Financial Incentives for Smoking Cessation

  Kevin G. Volpp;Andrea B. Troxel;Mark V. Pauly;Henry A. Glick

  268
  Citations

• The Economic Cost of Hip Fractures in Community‐Dwelling Older Adults: A Prospective Study

  Ada Brainsky;Henry Glick;Eva Lydick;Robert Epstein

  248
  Citations

• Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes

  Mark A. Espeland;Henry A. Glick;Alain Bertoni;Frederick L. Brancati

  212
  Citations

• What is the Cost of Nephrotoxicity Associated with Aminoglycosides

  John M. Eisenberg;Harris Koffer;Henry A. Glick;Margaret L. Connell

  211
  Citations

• Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

  Kevin A. Schulman;Lorna A. Lynn;Henry A. Glick;John M. Eisenberg

  195
  Citations

• Factors affecting decisions to seek treatment for sick children in Kerala, India

  Rajamohanan K Pillai;Sankey V Williams;Henry A Glick;Daniel Polsky

  192
  Citations

• Cholesterol measures to identify and treat individuals at risk for coronary heart disease.

  Sundar Natarajan;Henry Glick;Michael Criqui;David Horowitz

  188
  Citations

• Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.

  Kevin A. Schulman;Bruce Kinosian;Terry A. Jacobson;Henry Glick

  164
  Citations

• Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis

  Joseph T. King;Henry A. Glick;Thomas J. Mason;Eugene S. Flamm

  161
  Citations

• Estimating country‐specific cost‐effectiveness from multinational clinical trials

  Richard J. Willke;Henry A. Glick;Daniel Polsky;Kevin Schulman

  152
  Citations

• Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis

  Laura N. Venditti;Charles P. Venditti;Charles P. Venditti;Gerard T. Berry;Paige B. Kaplan

  149
  Citations